National HealthCare Corporation
HealthcareAMEX:NHC · New York Stock Exchange American
+$1.77 today
Vol 0.09M · Avg 0.12M
Growth Analysis
Test whether growth is durable
Review the core growth drivers, cash generation, analyst targets, and peer comparisons before deciding whether expectations still leave room for upside.
Big Five Numbers
CAGR by period · ROIC shows average
| Metric | 10yr | 5yr | 3yr | 1yr |
|---|---|---|---|---|
EPS | N/A | N/A | -3.6% | +1.9% |
Revenue | N/A | N/A | +6.0% | +4.0% |
Equity | +2.9% | +6.0% | +7.1% | +13.5% |
Cash | N/A | N/A | -36.1% | -81.1% |
ROIC | 4.6% | 4.0% | 3.6% | 4.0% |
Analysis
Latest growth is strongest in Equity at +13.5% and weakest in Cash at -81.1%. Three-year average ROIC is 3.6%, which helps show whether that growth is being earned efficiently.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | -3.6% | +12.1% (8yr)12 analysts |
| Revenue | N/A | N/A | +6.0% | +11.7% (8yr)12 analysts |
| Net Income | N/A | N/A | -3.6% | +15.7% (8yr)12 analysts |
| EBIT | N/A | N/A | -0.5% | +15.0% (8yr)12 analysts |
Analysis
Recent growth has been strongest in Revenue at +6.0% over three years. Forward estimates point to Net Income at +15.7% (8yr), giving you a quick check on whether expectations are accelerating or cooling.
Free Cash Flow
Net Income to FCF bridge
Analysis
Analysis will appear once cash flow data is available for this period.
Wall Street Price Targets
1-year price history with analyst consensus target
Current
$197.72
Low Target
—
Avg Target
—
High Target
—
Upside (Avg)
—
Competitor Growth
Peer CAGR comparison & forward estimates
No competitor data available.
Is NHC growing revenue?
Revenue grew 16.4% year over year, from $1.30B to $1.51B.
Is NHC turning growth into profit?
The latest net margin is 7.9%, which shows how much revenue became net income.
Explore More
Continue the stock analysis
Jump to another research area for this company.